Skip to main content
. Author manuscript; available in PMC: 2010 May 4.
Published in final edited form as: HIV Med. 2009 Jul 6;11(1):31–39. doi: 10.1111/j.1468-1293.2009.00738.x

Fig. 2.

Fig. 2

Reported reasons for stopping a drug when treatment was modified. (a) all drugs; (b) by country income category (b-1, low-income; b-2, high-income); (c) by type of treatment failure (c-1, immunological failure; c-2, virological failure; c-3, clinical progression), (d) by time from treatment failure (d-1, up to 90 days; d-2, 91–180 days; d-3, 181 days or more).